Kent, S. J., Zhao, A., Best, S. J., Chandler, J. D., Boyle, D. B., & Ramshaw, I. A. (1998). Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus. American Society for Microbiology.
Citación estilo ChicagoKent, Stephen J., Anne Zhao, Susan J. Best, Jenalle D. Chandler, David B. Boyle, and Ian A. Ramshaw. Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming With DNA and Boosting With Recombinant Fowlpox Virus. American Society for Microbiology, 1998.
Cita MLAKent, Stephen J., et al. Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming With DNA and Boosting With Recombinant Fowlpox Virus. American Society for Microbiology, 1998.